
TEL: +44 208 7482 221
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
La cellulite est l’une des principales préoccupations des patients d’esthétique médicale. Le marché des traitements n’est pas seulement vaste, il’ est en constante croissance, car 90 % des femmes et plus de 10 % des hommes sont préoccupés par de la cellulite tenace et inesthétique. La cellulite est clairement un problème courant que de nombreux patients sont désireux de traiter sans chirurgie ou sans apporter de changements draconiens à leur style de vie.
Venus Legacy™ est l’appareil idéal pour répondre aux préoccupations de vos patient’ concernant la cellulite. Alimenté par la technologie (MP)2 brevetée, qui combine la radiofréquence multipolaire et les champs électromagnétiques pulsés, et doté de l’aspiration pulsée réglable des produits VariPulse™, Venus Legacy™ réduit simultanément les cellules adipeuses et revitalise le collagène, améliorant ainsi l’apparence de la cellulite.
Une étude menée par des dermatologues internationaux de grande renommée a démontré que la technologie (MP)2 offerte par Venus Legacy™ est efficace pour réduire la cellulite abdominale de façon significative. Les patients étaient très satisfaits des résultats et n’ont ressenti aucun effet indésirable. Les résultats ont montré :
| Vue avant, avant | Vue avant, 12 semaines après le traitement complet |
![]() |
![]() |
| Vue latérale, avant | Vue latérale, 12 semaines après le traitement complet |
![]() |
![]() |
(Cliquez sur l’image pour voir la pleine grandeur)
| Avan | 1 semaine après le traitement complet |
![]() |
![]() |
(Cliquez sur l’image pour voir la pleine grandeur)
| Avant | 1 semaine après le traitement complet |
![]() |
![]() |
Venus Legacy™ offre la solution la plus avancée, non seulement pour la réduction de la cellulite, mais également pour le remodelage corporel*, le raffermissement de la peau*, and la réduction des rides. Alimentée par la (MP)2 brevetée, et dotée de l’innovant VariPulse™, la technologie est sécuritaire pour tous les types de peau et offre des traitements confortables aux patients, sans nécessiter de temps de récupération. Commencez à récolter les fruits d’un marché sans cesse croissant en dotant votre clinique d’un système rapide et efficace de réduction de la cellulite.
*Indications approuvées hors des États-Unis.



For more information call: (+44) 208 748 2221 // info.uk@venusconcept.com
REGULATORY CLEARANCES [ More ]
Venus Versa™ has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick. The AC Dual applicator has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ applicator has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The OctiPolar™ applicators on the Venus Versa™ system has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
ARTAS iX™ has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ has CE Mark for the increase of skin tightening, temporary circumferential reduction, cellulite reduction, and wrinkle reduction.
Venus Velocity™ has CE Mark for treatment of hirsutism (hair removal), permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Viva™ has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ has CE Mark for treatment of moderate to severe facial wrinkles and rhytides using the DiamondPolar™ applicator, and CE Mark for the treatment of cellulite reduction, increase of skin tightening, and temporary circumferential reduction on the OctiPolar™ applicator.
Venus Glow™ provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here